And did i miss when we went from having 400M share
Post# of 36537
Quote:
NuGenerex Immuno-Oncology, Inc. (“NGIO”), a Delaware corporation and subsidiary of Generex, has 750,000,000 authorized shares of common stock, 400,300,000 of which are outstanding,